Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J1CF
|
|||
| Former ID |
DIB010745
|
|||
| Drug Name |
Her2- and PSA-targeted TGX-D1
|
|||
| Synonyms |
KCC-TGX; Her2- and PSA-targeted TGX-D1 (prostate cancer); Her2-and PSA-targeted TGX-D1 (prostate cancer), University of Missouri
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Investigative | [1] | |
| Company |
University of Missouri
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Development of a peptide-drug conjugate for prostate cancer therapy. Mol Pharm. 2011 Jun 6;8(3):901-12. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.